Molecular Devices/ LJL BioSystems agree to merge:combing drug discovery capabilities
Article Abstract:
Sunnyvale, CA-based LJL BioSystems Inc. and Sunnyvale, CA-bsed Molecular Devices Corp. are merging. The combined company has a good handle on all aspects of drug discovery.
Publication Name: Genesis Report-Dx
Subject: Health care industry
ISSN: 1061-2289
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Histology: tissuepreparation capability added to analytical systems
Article Abstract:
Ventana recently signed a definitive agreement to buy all the outstanding equity of RMC (Biotechnology Tools) for about $5 million in cash. The move provides a strategic second point of entry in the histology market as well as added revenue.
Publication Name: Genesis Report-Dx
Subject: Health care industry
ISSN: 1061-2289
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
LJL Biosystems: automation alliance focuses on high throughput screening
Article Abstract:
Zymark Corp. and LJL BioSystems Inc. announced the first integration of Zymark's new Allegro automation technology combined with LJL's Analyst HTS Assay Detection System, to be used for high throughput screening in drug discovery applications.
Publication Name: Genesis Report-Dx
Subject: Health care industry
ISSN: 1061-2289
Year: 1999
User Contributions:
Comment about this article or add new information about this topic: